LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Novo Nordisk A/S Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$1.09M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -129K | $99.63 | 10.94K | |
| Q2 2022 | share | 0.00% | 0 shares | 4K | $111.43 | 10.94K | |
| Q1 2022 | share | 0.00% | 0 shares | -10K | $111.05 | 10.94K | |
| Q4 2021 | share | Decrease | -1.44% | -160 shares | 159K | $111.45 | 10.94K |
| Q3 2021 | share | Decrease | -7.65% | -920 shares | 59K | $96.01 | 11.10K |
| Q2 2021 | share | Decrease | -0.98% | -119 shares | 189K | $83.32 | 12.02K |
| Q1 2021 | share | Decrease | -0.22% | -27 shares | -31K | $67.06 | 12.14K |
| Q4 2020 | share | Increase | +2.31% | 275 shares | 24K | $68.52 | 12.17K |
| Q3 2020 | share | 0.00% | 0 shares | 47K | $68.1 | 11.9K | |
| Q2 2020 | share | Increase | +4.39% | 500 shares | 93K | $63.73 | 11.9K |
| Q1 2020 | share | Decrease | -29.15% | -4.69K shares | -245K | $58.59 | 11.4K |
| Q4 2019 | share | Decrease | -44.99% | -13.16K shares | -581K | $55.56 | 16.09K |
| Q3 2019 | share | Decrease | -19.24% | -6.97K shares | -337K | $49.63 | 29.25K |
| Q2 2019 | share | Decrease | -45.67% | -30.44K shares | -1.63M | $48.57 | 36.22K |
| Q1 2019 | share | Decrease | -88.81% | -529.27K shares | -23.96M | $49.78 | 66.66K |
| Q4 2018 | share | Decrease | -10.89% | -72.81K shares | -4.07M | $43.17 | 595.94K |
| Q3 2018 | share | Decrease | -7.88% | -57.23K shares | -1.95M | $44.17 | 668.75K |
| Q2 2018 | share | Decrease | -11.75% | -96.62K shares | -7.03M | $43.22 | 725.98K |
| Q1 2018 | share | Decrease | -21.13% | -220.33K shares | -15.46M | $46.15 | 822.60K |
| Q4 2017 | share | Decrease | -3.31% | -35.72K shares | 4.03M | $49.61 | 1.04M |
| Q3 2017 | share | Decrease | -3.78% | -42.38K shares | 4.40M | $44.5 | 1.07M |
| Q2 2017 | share | Decrease | -14.34% | -187.65K shares | 2.67M | $39.35 | 1.12M |
| Q1 2017 | share | Decrease | -9.97% | -144.85K shares | -7.26M | $31.45 | 1.30M |
| Q4 2016 | share | Decrease | -16.53% | -287.92K shares | -20.30M | $32.43 | 1.45M |
| Q3 2016 | share | Increase | +1.55% | 26.56K shares | -19.8M | $37.61 | 1.74M |
| Q2 2016 | share | Decrease | -0.82% | -14.18K shares | -1.47M | $48.3 | 1.71M |
| Q1 2016 | share | Decrease | -0.32% | -5.47K shares | -7.04M | $48.66 | 1.72M |